The Clinical Trials Guru's Dan Sfera on Innovation in Phase 1 Studies and BeyondHosted By : Andrea Charles
July 30, 2012
About this Podcast...
It’s no secret that pharma and bio are struggling to fill their pipelines. Dan Sfera from The Clinical Trials Guru, joins Andrea Charles from Pharma IQ to discuss specific challenges that arise in conducting Phase 1 studies and the additional skills that are required to overcome them, barriers to participation in early phase clinical trials and the potential challenges and opportunities of using biomarkers and when is the optimum time to start development.
Sfera also shares his insights on how NDA approval rates will be affected by regulatory changes and how increasing partnerships between pharmaceutical companies and CROs are changing the clinical development landscape.
Have Your Say
Rate this feature and give us your feedback in the comments section below
Taking EDC to the next level: Moving from point solutions to an eClinical ecosystem
April 4, 2013
Use of Cardiac Safety Data in Early Phase Trials to Supplement or Replace a Thorough QT Trial
June 11, 2012
Site Quality Management and Risk-Based Monitoring: A New Approach
December 4, 2012